This combination induces both apoptosis and ferroptosis through downregulation of NRF2 and HMOX1 and deactivation of GPX4, supporting ferroptosis as a potential co-target in aggressive DLBCL. The gene discussed is GPX4; the disease is diffuse large B-cell lymphoma.